Lipo-B injections are typically used as a supplemental aid to weight loss, intended to complement a healthy diet and exercise regimen
GHK-Cu is a non-hormonal tripeptide complex, classified as a matrikine a compound naturally released during tissue injury to signal repair processes
S.DasS.KunduS.AdegokeE
= reduced peptide bond (CH 2 -NH 2 ) Family # Ri- R3 1 2 3 1 hexanoyl pb pb pb heptanoyl Y pb pb pb pentanoyl Y pb pb pb butanoyl Y pb pb pb propanoyl Y pb pb pb acetanoyl Y pb pb pb isopropanoyl Y pb pb pb tert-butanoyl Y pb pb pb isobutanoyl Y pb pb pb benzoyl Y pb pb pb hexanoyl Y pb pb heptanoyl Y P b P b pentanoyl Y pb pb butanoyl Y pb pb propanoyl Y pb pb acetanoyl Y pb pb isopropanoyl Y pb pb tert-butanoyl Y pb pb isobutanoyl Y pb pb benzoyl Y pb pb hexanoyl 5 pb heptanoyl 5 pb pentanoyl 5 pb butanoyi 5 pb propanoyl 5 pb acetanoyl 5 pb isopropanoyl 5 pb tert-butanoyl 5 pb isobutanoyl 5 pb benzoyl 5 pb hexanoyl 5 pb pb heptanoyl 5 pb pb pentanoyl 5 pb pb butanoyi 5 pb pb propanoyl 5 pb pb acetanoyl 5 pb pb isopropanoyl 5 pb pb tert-butanoyl 5 pb b isobutanoyl 5 pb pb benzoyl 5 pb pb hexanoyl 5 pb pb pb heptanoyl 5 pb pb pb pentanoyl 5 pb pb pb butanoyi 5 pb pb pb propanoyl 5 pb pb pb acetanoyl 5 pb pb pb isopropanoyl 5 pb pb pb tert-butanoyl 5 pb pb pb isobutanoyl 5 p pb pb benzoyl F I 5 pb pb pb hexanoyl pb pb heptanoyl pb pb pentanoyl pb pb butanoyl pb pb propanoyl pb pb acetanoyl pb pb isopropanoyl pb pb tert-butanoyl pb pb isobutanoyl pb pb benzoyl pb pb hexanoyl pb heptanoyl P b pentanoyl pb butanoyl pb propanoyl pb acetanoyl pb isopropanoyl pb tert-butanoyl pb isobutanoyl pb benzoyl pb hexanoyl pb pb heptanoyl pb pb pentanoyl pb pb butanoyl pb pb propanoyl pb pb acetanoyl pb pb isopropanoyl pb pb tert-butanoyl F pb pb isobuianoyl F pb pb benzoyl F 5 pb pb hexanoyl C pb pb pb heptanoyl C pb pb pb pentanoyl c pb pb pb butanoyl c pb pb pb propanoyl c pb pb pb acetanoyl c pb b pb isopropanoyl c pb pb pb tert-butanoyl c pb pb pb isobutanoyl c pb pb pb benzoyl c pb pb pb hexanoyl C Pb pb heptanoyl C pb pb pentanoyl C pb pb butanoyl c pb pb propanoyl c pb pb acetanoyl c pb pb isopropanoyl c pb pb tert-butanoyl c 5 pb pb isobutanoyl c pb pb benzoyl c pb pb hexanoyl C pb heptanoyl C pb pentanoyl c pb butanoyl c pb propanoyl c pb pb pb pb pb pb hexanoyl C pb pb heptanoyl C pb pb pentanoyl C pb pb butanoyl C pb pb propanoyl C pb pb acetanoyl c pb pb isopropanoyl c pb pb tert-butanoyl c pb pb isobutanoyl c pb b benzoyl c pb pb 1 -16 Same pattern as families I -4 with R2=S 17-20 Same pattern as families 1 -4 with R2-T 21 -24 Same pattern as families 1 -4 with R2=D 25-28 Same pattern as families 1 -4 with R2=E 29-32 Same pattern as families 1 -4 with R2=Y, R3=V 33-36 Same pattern as families 1 -4 with R2=F, R3=V 37-40 Same pattern as families 1 -4 with R2= , R3=V 41 -44 Same pattern as families 1 -4 with R2=S, R3=V 45-48 Same pattern as families 1-4 with R2=T, R3=V 49-52 Same pattern as families 1 -4 with R2=D, R3=V 53-56 Same pattern as families 1 -4 with R2=E, R3=V 57-85 Same pattern as families 29-56 with R3=L 86-170 Same pattern as families 1-85 with n=3 342 D-norleucine Y I 5 pb pb pb D-norleucine F I 5 pb pb pb D-norleucine C I 5 pb pb pb D-norleucine S I 5 pb pb pb D-norleucine T I 5 pb pb pb D-norlencine D I 5 pb pb pb D-norleucine E I 5 pb pb pb D-norleucine G I 5 pb pb pb 343 D-norleucine Y I 5 pb pb D-norleucine F I 5 pb pb D-norleucine C I 5 pb pb D-norleucine S I 5 pb pb D-norleucine T 1 5 pb pb D-norleucine D I 5 pb pb D-norleucine E I 5 pb pb D-norleucine G I 5 pb pb 344 D-norleucine Y I 5 pb pb D-norleucine F I 5 pb pb D-norleucine C I 5 Pb pb D-norleucine S I 5 pb pb D-norleucine T I 5 pb pb D-norleucine D I 5 pb pb D-norleucine E I 5 pb pb D-norleucine G I 5 pb pb 345 D-norleucine Y I 5 pb D-norleucine F I 5 pb D-norleucine C I 5 pb D-norleucine S I 5 pb D-norleucine T I 5 pb D-norleucine D I 5 pb D-norleucine E I 5 pb D-norleucine G I 5 pb 346-349 Same pattern as families 342-345 with R3=V 350-353 Same pattern as families 342-345 with R3=L 354-365 Same pattern as families 342-353 with R1=D norvaline 366-377 Same pattern as families 342-345 with R3=D-lysine 378-389 Same pattern as families 342-345 with R3=D-arginine 390-401 Same pattern as families 342-345 with R3=D S-methyl cysteine 402-457 Same pattern as families 342-401 with n=3 458-513 Same pattern as families 342-401 with n=4 514-569 Same pattern as families 342-401 with n=6 Alternatively, the analogs or growth factor mimics of the present invention may also be represented as comprised of four elements joined by covalent peptide or reduced peptide bonds, as follows: I - II - III - rv where I = an acid such as heptanoic, hexanoic, pentanoic, butyric, proprionic, acetic, benzoic, or substituted benzoic acid, and isoforms thereof
This does not change the reconstitution process, but it does mean the side effect profiles during dose escalation can differ
The regulatory gaps that exist for research chemicals place full responsibility for safety and quality on the individual - a significant burden that should be approached with realistic expectations about the current state of evidence
,aspect=ignore)
